{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:30:09Z","timestamp":1790757009888,"version":"4.1.0"},"reference-count":41,"publisher":"Society of Nuclear Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.2967\/jnumed.119.233411","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T23:45:22Z","timestamp":1575589522000},"page":"1030-1036","source":"Crossref","is-referenced-by-count":127,"title":["Radiation Dosimetry in <sup>177<\/sup>Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT\/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors"],"prefix":"10.2967","volume":"61","author":[{"given":"Price A.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Scalzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Violet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"key":"2021051712150081000_61.7.1030.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.07.1754"},{"key":"2021051712150081000_61.7.1030.2","first-page":"610","article-title":"Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor","volume":"44","author":"Smith-Jones","year":"2003","journal-title":"J Nucl Med."},{"key":"2021051712150081000_61.7.1030.3","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.10661"},{"key":"2021051712150081000_61.7.1030.4","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910620511"},{"key":"2021051712150081000_61.7.1030.5","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0045(20000501)43:2<150::AID-PROS10>3.0.CO;2-B"},{"key":"2021051712150081000_61.7.1030.6","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.207993"},{"key":"2021051712150081000_61.7.1030.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2713-y"},{"key":"2021051712150081000_61.7.1030.8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13550-015-0114-2","article-title":"Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study","volume":"5","author":"Ahmadzadehfar","year":"2015","journal-title":"EJNMMI Res."},{"key":"2021051712150081000_61.7.1030.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.183194"},{"key":"2021051712150081000_61.7.1030.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.171397"},{"key":"2021051712150081000_61.7.1030.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.02.2969"},{"key":"2021051712150081000_61.7.1030.12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00259-016-3481-7","article-title":"177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment","volume":"44","author":"Yadav","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712150081000_61.7.1030.13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1470-2045(18)30198-0","article-title":"[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study","volume":"19","author":"Hofman","year":"2018","journal-title":"Lancet Oncol."},{"key":"2021051712150081000_61.7.1030.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.219352"},{"key":"2021051712150081000_61.7.1030.15","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-016-0942-0"},{"key":"2021051712150081000_61.7.1030.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3174-7"},{"key":"2021051712150081000_61.7.1030.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3125-3"},{"key":"2021051712150081000_61.7.1030.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.178483"},{"key":"2021051712150081000_61.7.1030.19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MNM.0000000000000606","article-title":"Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer","volume":"38","author":"Yadav","year":"2017","journal-title":"Nucl Med Commun."},{"key":"2021051712150081000_61.7.1030.20","first-page":"123","article-title":"177Lu-PSMA-617 therapy, dosimetry and follow-up in patients with metastatic castration-resistant prostate cancer [in German]","volume":"55","author":"Fendler","year":"2016","journal-title":"Nucl Med (Stuttg)."},{"key":"2021051712150081000_61.7.1030.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1422-4"},{"key":"2021051712150081000_61.7.1030.22","first-page":"37S","article-title":"MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates","volume":"40","author":"Siegel","year":"1999","journal-title":"J Nucl Med."},{"key":"2021051712150081000_61.7.1030.23","first-page":"1023","article-title":"OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine","volume":"46","author":"Stabin","year":"2005","journal-title":"J Nucl Med."},{"key":"2021051712150081000_61.7.1030.24","first-page":"11S","article-title":"MIRD pamphlet no. 17: the dosimetry of nonuniform activity distributions\u2014radionuclide S values at the voxel level","volume":"40","author":"Bolch","year":"1999","journal-title":"J Nucl Med."},{"key":"2021051712150081000_61.7.1030.25","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1118\/1.597046","article-title":"MIRD formulation","volume":"20","author":"Watson","year":"1993","journal-title":"Med Phys."},{"key":"2021051712150081000_61.7.1030.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.056036"},{"key":"2021051712150081000_61.7.1030.27","doi-asserted-by":"crossref","first-page":"112503","DOI":"10.1118\/1.4824318","article-title":"An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT\/CT imaging","volume":"40","author":"Jackson","year":"2013","journal-title":"Med Phys."},{"key":"2021051712150081000_61.7.1030.28","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/mp.12886","article-title":"Single time point dose estimate for exponential clearance","volume":"45","author":"Madsen","year":"2018","journal-title":"Med Phys."},{"key":"2021051712150081000_61.7.1030.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.193706"},{"key":"2021051712150081000_61.7.1030.30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1470-2045(18)30198-0","article-title":"[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study","volume":"19","author":"Hofman","year":"2018","journal-title":"Lancet Oncol."},{"key":"2021051712150081000_61.7.1030.31","doi-asserted-by":"crossref","first-page":"56\u201366","DOI":"10.1102\/1470-7330.2011.0012","article-title":"Quantitative 177Lu SPECT (QSPECT) imaging using a commercially available SPECT\/CT system","volume":"11","author":"Beauregard","year":"2011","journal-title":"Cancer Imaging."},{"key":"2021051712150081000_61.7.1030.32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.219352"},{"key":"2021051712150081000_61.7.1030.33","doi-asserted-by":"publisher","DOI":"10.1109\/TMI.2009.2035616"},{"key":"2021051712150081000_61.7.1030.34","unstructured":"Contour-guided registration. GitHub website. https:\/\/github.com\/jacksonmedphysics\/contour-guided-registration. Accessed March 10, 2020."},{"key":"2021051712150081000_61.7.1030.35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3413\/Nukmed-0925-17-08","article-title":"Absorbed dose estimates from a single measurement one to three days after the administration of 177Lu-DOTATATE\/-TOC","volume":"56","author":"H\u00e4nscheid","year":"2017","journal-title":"Nuklearmedizin."},{"key":"2021051712150081000_61.7.1030.36","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.171397"},{"key":"2021051712150081000_61.7.1030.37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejrad.2019.01.028","article-title":"Deep learning for segmentation of 49 selected bones in CT scans: first step in automated PET\/CT-based 3D quantification of skeletal metastases","volume":"113","author":"Belal","year":"2019","journal-title":"Eur J Radiol."},{"key":"2021051712150081000_61.7.1030.38","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fonc.2018.00215","article-title":"Deep learning renal segmentation for fully automated radiation dose estimation in unsealed source therapy","volume":"8","author":"Jackson","year":"2018","journal-title":"Front Oncol."},{"key":"2021051712150081000_61.7.1030.39","first-page":"30","article-title":"Automated detection and quantification of prostatic PSMA uptake in SPECT\/CT using a deep learning algorithm for segmentation of pelvic anatomy [abstract]","volume":"59","author":"Sjostrand","year":"2018","journal-title":"J Nucl Med."},{"key":"2021051712150081000_61.7.1030.40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4274\/mirt.08760","article-title":"Lu-177-PSMA-617 prostate-specific membrane antigen inhibitor therapy in patients with castration-resistant prostate cancer: stability, bio-distribution and dosimetry","volume":"26","author":"Kabasakal","year":"2017","journal-title":"Mol Imaging Radionucl Ther."},{"key":"2021051712150081000_61.7.1030.41","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.218917"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.119.233411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:50:12Z","timestamp":1621284612000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.119.233411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,5]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,1]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.2967\/jnumed.119.233411"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.119.233411","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,5]]}}}